Latest Security News

Nexsen Limited has successfully completed an $8 million IPO and ASX listing, while advancing its kidney diagnostic tests and initiating clinical trials for its GBS Rapid Sensor targeting expedited FDA approval.

EVE Health Group has taken significant strides in commercialising its women’s and men’s health products Dyspro™ and Libbo™, securing regulatory clearances, first patient prescriptions, and raising $1.1 million to support market expansion.

Galilee Energy reported steady cash reserves and ongoing reservoir pressure monitoring at its Glenaras Gas Project, while exploring new funding and growth opportunities.

Vitasora Health Limited reported robust patient program growth and secured new US partnerships, driving revenue above A$1 million for the quarter. A recent A$11 million capital raise positions the company for continued expansion and cash-flow breakeven by late 2026.

Bowen Coking Coal maintained steady production and sales in Q3 2025 while slashing costs by a third through a new mining model, despite ongoing administration and receivership. The company generated positive operating cash flow and advanced key development projects.

Winchester Energy reported a slight dip in production but secured a strategic 30% farm-out deal for its Varn waterflood project, alongside significant board restructuring.

Hastings Technology Metals and Wyloo have signed a non-binding agreement with Ucore Rare Metals to negotiate a long-term offtake for rare earth concentrate and explore US-based downstream processing.

Simble Solutions reports new multi-year contracts in the UK and Australia, boosting revenue prospects, but faces a cash runway of less than one quarter and is exploring funding options.

Mayfield Childcare Limited reported a 5% revenue increase and a 14% rise in underlying EBITDA for Q3 FY25, alongside a $2.4 million debt reduction and an extended borrowing facility. The company also ended a planned divestment and announced a new community partnership.

NoviqTech Limited has launched Fuel Central for sustainable fuels traceability and established Quantum Intelligence Pty Ltd to advance quantum computing and AI applications, backed by a $1.08 million placement. The company also refreshed its board and expanded its international footprint.

Imugene Limited reports an 81% overall response rate in its azer-cel CAR T-cell therapy trial for difficult lymphomas, alongside a $25 million capital raise that extends its cash runway to mid-2027.

Stakk Limited reports a staggering 1,836% year-on-year increase in quarterly receipts, positioning itself on track to hit an $8 million annual recurring revenue target by mid-2026.